These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 29263458)

  • 1. Creatine kinase-MB and red cell distribution width as predictors of contrast-induced nephropathy after percutaneous coronary intervention in acute myocardial infarction.
    Zbierska-Rubinkiewicz K; Trębacz O; Tomala M; Rubinkiewicz M; Chrzan I; Gackowski A
    Folia Med Cracov; 2017; 57(3):87-99. PubMed ID: 29263458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of hemoglobin-to-red blood cell distribution width ratio for contrast-induced nephropathy after emergency percutaneous coronary intervention.
    Sun X; Zhang R; Fan Z; Liu Z; Hua Q
    Perfusion; 2023 Oct; 38(7):1511-1518. PubMed ID: 35950360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.
    Victor SM; Gnanaraj A; S V; Deshmukh R; Kandasamy M; Janakiraman E; Pandurangi UM; Latchumanadhas K; Abraham G; Mullasari AS
    Indian Heart J; 2014; 66(5):517-24. PubMed ID: 25443605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the development of contrast‑induced nephropathy following percutaneous coronary artery intervention by machine learning.
    Ma X; Mo C; Li Y; Chen X; Gui C
    Acta Cardiol; 2023 Oct; 78(8):912-921. PubMed ID: 37052397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact and predictors of persistent renal dysfunction in acute kidney injury after percutaneous coronary intervention for acute myocardial infarction.
    Nakamura T; Watanabe M; Sugiura J; Kyodo A; Nobuta S; Nogi K; Nakada Y; Ishihara S; Hashimoto Y; Nakagawa H; Ueda T; Seno A; Nishida T; Onoue K; Hikoso S
    Sci Rep; 2024 Mar; 14(1):6299. PubMed ID: 38491142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of systemic inflammation-response index in predicting contrast-induced nephropathy in patients with ST-elevation myocardial infarction.
    Yildiz C; Yuksel Y; Efe SC; Altintas MS; Katkat F; Ayca B; Karabulut D; Çağlar FNT; Köse S
    Acta Cardiol; 2023 Oct; 78(8):930-936. PubMed ID: 37293996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum total bilirubin level is associated with contrast induced nephropathy after primary percutaneous coronary intervention.
    Özilhan MO; Açıkgöz SK
    Angiology; 2023; 74(10):981-986. PubMed ID: 37368236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of hemoglobin and left ventricular ejection fraction as a new predictor of contrast induced nephropathy in patients with non-ST elevation myocardial infarction.
    Ugur M; Uluganyan M; Ekmekci A; Bozbay M; Karaca G; Cicek G; Koroglu B; Tusun E; Murat A; Turan B; Uyarel H; Orhan AL; Eren M
    Med Sci Monit; 2014 Jun; 20():967-73. PubMed ID: 24920294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of inflammatory prognostic index for contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Jiang Y; Luo B; Chen Y; Peng Y; Lu W; Chen L; Lin Y
    Sci Rep; 2024 Jul; 14(1):15861. PubMed ID: 38982273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study.
    Chen F; Lu J; Yang X; Liu D; Wang Q; Geng X; Xiao B; Zhang J; Liu F; Gu G; Cui W
    BMC Cardiovasc Disord; 2023 Jun; 23(1):323. PubMed ID: 37355592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-urea-nitrogen-to-serum-albumin ratio in predicting the value of patients with contrast-induced nephropathy for coronary heart disease.
    Pan Q; Peng Y; Ni H; Lin L; Luo B; Huang X; Chen L; Lin Y
    Int Urol Nephrol; 2024 Jun; 56(6):2075-2083. PubMed ID: 38281310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Injury Molecule-1 Is Associated with Contrast-Induced Nephropathy in Elderly Patients with Non-STEMI.
    Huyut MA
    Arq Bras Cardiol; 2021 Jun; 116(6):1048-1056. PubMed ID: 33787767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for contrast induced nephropathy: a study among Italian patients.
    Evola S; Lunetta M; Macaione F; Fonte G; Milana G; Corrado E; Bonura F; Novo G; Hoffmann E; Novo S
    Indian Heart J; 2012; 64(5):484-91. PubMed ID: 23102387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy.
    Kabeer MA; Cross J; Hamilton G; Rashid ST
    Angiology; 2021 Mar; 72(3):274-278. PubMed ID: 33228378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction.
    Özkan U; Gürdoğan M
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984506
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between Pan-Immune-Inflammation Value and Contrast-Induced Nephropathy with Coronary Angiography.
    Akkaya S; Cakmak U
    Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929630
    [No Abstract]   [Full Text] [Related]  

  • 17. Spironolactone for Preventing Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease.
    Lu Y; Ni W; Qu X; Chen C; Shi S; Guo K; Lin K; Zhou H
    Angiology; 2024 Apr; ():33197241251889. PubMed ID: 38679489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of low hemoglobin on the development of contrast-induced nephropathy: A retrospective cohort study.
    Xu J; Zhang M; Ni Y; Shi J; Gao R; Wang F; Dong Z; Zhu L; Liu Y; Xu H
    Exp Ther Med; 2016 Aug; 12(2):603-610. PubMed ID: 27446250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Remnant Cholesterol and Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention.
    Luo B; Huang X; Peng Y; Luo H; Chen L; Lin Y
    Angiology; 2024 Jan; ():33197231225862. PubMed ID: 38185982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of contrast-induced nephropathy].
    Cousin F; Moïse M; Ilbert C; Meunier P; Jouret F
    Rev Med Liege; 2024 Jun; 79(5-6):418-423. PubMed ID: 38869133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.